ASML's 5% Jump Shows AI Demand Is Still Alive - but the Real Test Starts Now

AI demand is still lifting ASML's core bottleneck story

Investors are still paying a premium for AI infrastructure, and ASML remains one of the clearest ways to own the hardware side of the boom. Lithography is how circuits actually get printed on advanced wafers, so even the strongest AI software demand eventually runs into a hardware constraint if tool supply cannot keep pace. In simple terms: no EUV tools, no advanced AI chips.

That helps explain the valuation premium. After an around 35% 2026 advance, ASML still posted Q2 gross margin of 54.0% and now expects 2026 total net sales to be between €43 billion and €45 billion, with a gross margin between 54% and 56%. That followed the April reset, when management lifted the outlook as demand for AI chipmaking tools continues to rise.

The tension is straightforward. Bulls see durable pricing power at a critical bottleneck. Bears see timing risk, China demand declines, and a stock that may already be richly priced. The demand case is getting easier to support; the valuation debate is not going away.

ASML's latest quarter strengthened the quality of the growth story

Sales, shipments, and service revenue all improved

The share move was the headline, but the better-quality revenue stream matters more. In Q2, ASML reported €9.3 billion in total net sales, 86 new lithography systems sold, and net income of €2.9 billion. Installed Base Management sales also rose to €2.762 billion from €2.488 billion a year earlier. That mix matters because service-related revenue tends to be more persistent than one-off system deliveries.

When new-tool sales and installed-base revenue both hold up, it suggests customers are not only ordering more equipment but also keeping existing systems operational and upgraded over time. That is a healthier pattern than growth driven by a single shipment spike.

Margin guidance shows the profit lever is still intact

ASML's margins remain the clearest evidence that demand is not coming at the expense of profitability. The company delivered Q2 gross margin of 54.0% and now expects 2026 total net sales to be between €43 billion and €45 billion, with a gross margin between 54% and 56%, up from the earlier 51% to 53% range. That does not prove permanent pricing power, but it does show the business is still scaling without a meaningful squeeze on gross margin.

Backlog conversion, not just backlog size, is the real watchpoint

The latest outlook also pushes the full-year picture higher. ASML now expects €43 billion to €45 billion in 2026 sales, and management said orders were "extremely strong" in the first half as customers accelerated AI capacity plans. That gives the medium-term case more substance, but the key test is conversion: can that pipeline turn into steady shipments, margins, and cash over the next few years?

For investors, that is the real next test. Not today's move, but whether service growth, system deliveries, and margin guidance keep improving together. If they do, earnings power should continue catching up to the story. If not, the debate shifts back to timing risk and China demand declines.

The market is now debating pricing power versus expectations

The bullish case: margins are the proof

If ASML still has unusual leverage in its market, that should show up in both bookings and margins. The latest guide is encouraging on both fronts. Management now expects Q3 2026 total net sales between €11.0 billion and €12.0 billion and a gross margin between 55% and 57%. After the stock's around 35% 2026 advance and the fact that ASML raised its 2026 revenue outlook, the message is that stronger demand is also supporting profitability.

That is what a resilient bottleneck business can look like in practice: not just more orders, but orders that still leave room for healthy margins.

The bearish case: much of the good news may already be priced in

The skeptical view is simpler. ASML already had its rerating. With a relatively high valuation and a stock that has surged 115% this year, investors are assuming a near-flawless execution path. Bears also point to concerns around China demand declines and the fact that management had previously signaled 2026 could be flat to slightly up versus 2025. That does not mean the demand story has broken; it means the margin for disappointment is smaller.

What would confirm or weaken the case from here

Stay constructive if the next update shows: - Q3 sales landing in or above Q3 2026 total net sales between €11.0 billion and €12.0 billion - Gross margin meeting or beating 55% to 57% - No material new weakness tied to China exposure

Step back if: - Sales come in below the Q3 guide - Margins slip below the 55% to 57% band - Policy or export pressure starts to disrupt backlog conversion

Rule of thumb: stay constructive while margin guidance keeps moving the right way, because that signals real business leverage. Get stricter on valuation if growth still looks solid but the margin story stops improving.